CML is the first human tumor that has been shown to be associated with chromosomal abnormalities, as patients have translocated chromosomes 9 and 22, forming a new BCR-ABL fusion gene. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.